Dual secretagogue research blend
Combines CJC-1295 No DAC and Ipamorelin at 5 mg each to study two complementary receptor systems.

PERFORMANCE / RESEARCH COMPOUND
5+ vials: 10% off
Analytical results apply to a specific sample, batch and test method. Ask about the exact lot being offered; do not assume a generic purity figure or test panel applies to every batch.
Understand Batch Test Reports ↗For laboratory research use only. Not for human consumption. No treatment or self-administration guidance is provided.
This paired profile combines a short-acting GHRH analogue with a selective ghrelin-receptor agonist. Pep-Pedia presents the pairing as a pulsatile growth-hormone research protocol while explicitly noting that combination trials are absent.
Combines CJC-1295 No DAC and Ipamorelin at 5 mg each to study two complementary receptor systems.
A dual-component endocrine-signalling research blend; compare vial presentations and composition.
Explore receptor targets and downstream signalling studied for this compound.
The No DAC analogue is framed around pituitary GHRH signalling.
View primary studyEngages the growth-hormone secretagogue receptor pathway.
View primary studyCalcium entry connects receptor signalling to hormone secretion.
View primary studyStimulates hormone release from GH-producing pituitary cells.
View primary studyExpand each group. Categories follow the linked Pep-Pedia source profile. Labels describe relative research emphasis and are not clinical efficacy grades.
Growth hormone elevation supports muscle protein synthesis and nitrogen retention during training
Sustained GH patterns may accelerate muscle repair between exercise sessions
GH optimization helps maintain muscle during caloric restriction or aging
Growth hormone promotes lipolysis while supporting lean tissue maintenance
Enhanced GH patterns may improve glucose and fat utilization
Improved sleep quality and recovery supports overall energy levels
Evening GH peaks align with deeper, more restorative sleep patterns
Sustained GH elevation supports skin elasticity and connective tissue health
Growth hormone plays roles in neuroplasticity and cognitive function
Growth hormone supports tissue repair and recovery from exercise or injury
Optimized GH patterns may support anti-inflammatory processes
Enhanced collagen synthesis supports joint and connective tissue integrity
Pep-Pedia community poll distributions. Every response option returned for each displayed question is shown.
Anonymous self-reporting is subject to selection bias and is not clinical evidence. Percentages describe community responses and may not total exactly 100% because of rounding. Snapshot captured 2026-10-16; the source refreshes in the background.
Research context belongs beside—not above—the safety and evidence boundary.
* Source context: Pep-Pedia research profile ↗. This catalogue uses a research-only summary and does not reproduce protocol or self-use instructions.
Weeks 1–2 · deeper sleep and more vivid dreams are commonly reported
Weeks 3–4 · reports may include easier exercise recovery, less soreness and improved energy
Weeks 6–8 · gradual body-composition, skin and general wellbeing changes may be noticed
Weeks 8–12 · the source describes this as the main window for judging whether the combination is producing noticeable effects
After observation · some sleep- and recovery-related changes may persist for several weeks
Study type is part of the product information. Laboratory, animal, observational and controlled human findings are not interchangeable.
Growth hormone elevation supports muscle protein synthesis and nitrogen retention during training
Growth hormone promotes lipolysis while supporting lean tissue maintenance
Evening GH peaks align with deeper, more restorative sleep patterns
Growth hormone supports tissue repair and recovery from exercise or injury
Curated starting points, not a systematic review, comparative ranking or batch-test record. Follow the source for the full methods and results.
| Source | Study model | Measured topic and limitations |
|---|---|---|
| Long-acting CJC-1295 endocrine study ↗Teichman et al. · 2006 · PMID 16352683 | Two randomised placebo-controlled studies in healthy adults | Measures pharmacokinetics, growth hormone and IGF-I over 28- and 49-day study periods. This is long-acting CJC-1295 evidence. Do not reuse its duration or pharmacokinetics as measurements for a No DAC / modified GRF 1-29 product. |
| Ipamorelin secretagogue pharmacology ↗Raun et al. · 1998 · PMID 9849822 | Rat pituitary cells, rats and swine | Compares growth-hormone release and other hormonal responses with comparator secretagogues. Species, experimental setup and measured endpoints matter; the study is not a trial of the CJC + Ipamorelin blend. |
CJC-1295 No DAC identity and evidence · Ipamorelin research evidence · CJC + Ipamorelin blend vs single vials · CJC material forms · Blend vs separate vials · Batch COA checklist · Presentation and blend labels · Publisher and source policy
The currently listed INR prices are 10 mg: ₹7,999; 20 mg: ₹12,000. The prices above are for the labelled research presentations. Confirm availability, delivery charges and the final order total before payment.
Keep the CJC form and both component amounts explicit. A label stating 5 mg CJC-1295 No DAC + 5 mg Ipamorelin describes 10 mg total, not 10 mg of each constituent. Do not infer a component ratio from a total-only label, or treat DAC-linked CJC-1295 as the No DAC form.
CJC No DAC + Ipamorelin; CJC-Ipa blend are names used in material searches. A two-constituent blend combining a No DAC GHRH-related material and Ipamorelin. Check both component amounts. Match the full label, form and batch documents; an alias alone does not authenticate a product.
A two-constituent blend combining a No DAC GHRH-related material and Ipamorelin. Check both component amounts. A growth-hormone-secretagogue research peptide studied at the ghrelin receptor. Compare identity, component amounts and the actual study model. Shared research topics do not establish equivalent effects.
Delivery enquiries are welcome for these cities and other Indian destinations, subject to the actual PIN code. Standard delivery: ₹150, estimated 3–5 days. Express delivery: ₹350, estimated 2–3 days. Cash on delivery adds ₹150. Confirm PIN-code serviceability and the delivery estimate before ordering.
Returns and refunds are available for products damaged on arrival or if purity is below 99%. Retain the order reference, packaging and relevant batch records; contact the team to confirm the claim process.
Select the labelled presentation and quantity, review the cart, then send the order enquiry on WhatsApp. Share your Indian PIN code so the team can confirm stock, serviceability, delivery charges and the final INR total before payment. The listed material is for laboratory research only, not for human consumption.
Use the batch COA request link on this page and specify the selected presentation. Ask the team to match available documentation to the current batch and confirm delivery to your Indian PIN code before payment. Compare the report identity, test method and measured result with the material offered.
Standard delivery across India costs ₹150 and usually takes 3–5 days. Express delivery costs ₹350 and usually takes 2–3 days. Cash on delivery is available for an extra ₹150. The team confirms serviceability for your PIN code and the final total on WhatsApp before dispatch.
Yes. The Peptide Co. ships from Bengaluru to eligible PIN codes across India, including Mumbai, Delhi NCR, Bengaluru (Bangalore), Hyderabad, Chennai, Pune, Kolkata and Ahmedabad. Share your PIN code on WhatsApp to confirm serviceability and the delivery estimate for your address.
CJC-1295 No DAC + Ipamorelin is also known as CJC No DAC + Ipamorelin, CJC-Ipa blend. These names describe the same listing on this page; always match the labelled identity and batch documentation rather than relying on a name alone.
The blend supplies CJC-1295 No DAC and Ipamorelin in one vial at a fixed labelled split; single vials list each compound separately. Our CJC + Ipamorelin blend vs single vials guide explains the label arithmetic and what to compare on price. Read the guide at thepeptideco.in/guides/cjc-ipamorelin-blend-vs-separate.
As of 1 November 2026, this page shows 2 listed presentations for CJC-1295 No DAC + Ipamorelin, and prices on the page are read from the live catalogue each time it loads. Current availability is shown with the listed sizes. Your final total is confirmed on WhatsApp.
CJC-1295 No DAC + Ipamorelin is classified as dual secretagogue research blend. Combines CJC-1295 No DAC and Ipamorelin at 5 mg each to study two complementary receptor systems.
Its principal research areas are dual-pathway secretagogue models, GHRH and GHS-R1a signalling, comparative endocrine kinetics. These describe experimental topics, not guaranteed outcomes or approved indications.
10 mg · 20 mg lyophilized research material in a sealed glass vial. Appearance: White to off-white lyophilized powder. Always compare the received vial with its lot-specific documentation.
Keep sealed, dry and protected from light/moisture. Store at 2–8°C short-term and ≤−20°C long-term unless the batch documentation states otherwise.
Research blend; not approved for human use. This catalogue presentation is restricted to laboratory research material and does not provide dosing, treatment or self-administration guidance.